Trial intelligence / Profile preview

Ezetimibe in children with familial hypercholesterolemia

NL-OMON25426Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in familial hypercholesterolemia (FH) comparing Ezetimibe with Placebo (2 arms). Primary endpoints: LDL-cholesterol efficacy and Safety of ezetimibe 10 mg. Started Aug 2006; status: active, not recruiting.

02

Drugs

ezetimibe
03

Conditions

familial hypercholesterolemia (FH)

Beyond the preview

Go deeper on NL-OMON25426.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25426.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call